Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 266 participants.
Also called NCT01336738
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 266 participants
- Sponsor
- Registry
-
NCT01336738
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Hungary, Mexico, Slovakia, South Korea, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01336738. Randomized; double masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2013-08-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
- Condition
- Diabetes, Type 2
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- 150 mg PF-04991532
- Intervention (Drug)
- 450 mg PF-04991532
- Intervention (Drug)
- 750 mg PF-04991532
- Intervention (Drug)
- Sitagliptin 100 mg
- Lead sponsor
- Pfizer
Record details
- Record id
cardio:ct-nct01336738- Content hash
d491c89402b8c4823ad81b02c2493a8054af50eb4a7c3b5370cfc076e72c0bc1